Tianjin Medical University General Hospital

This study tests whether using a patient's own immune cells, called tumor-infiltrating lymphocytes (TILs), is safe for treating early-stage non-small cell lung cancer. About 50 adults with multiple lung nodules will receive TILs therapy. The main goal is to check for side effects…

This early-phase study tests whether combining a patient's own tumor-fighting immune cells (TILs) with a newer targeted drug can be safe for people with advanced lung cancer that no longer responds to standard targeted therapy. About 50 adults aged 18-75 with EGFR-mutant non-smal…

This phase 3 trial tests whether giving a large amount of IV saline (about 2-2.5 liters) right after clot-busting treatment helps people recover better from a stroke. Researchers will compare this to giving only a small amount of fluids. The study plans to enroll 752 adults aged …

This study tests if a pain medicine called oliceridine can prevent long-term pain after lung surgery. About 320 adults having lung surgery will get either oliceridine or a standard pain medicine. Researchers will check pain levels for up to 3 months after surgery to see if olicer…

This study looks at whether roxadustat, a drug used to treat anemia in kidney disease, can also reduce muscle loss (sarcopenia) in people on hemodialysis. About 60 adults with end-stage kidney disease and anemia will receive either roxadustat or standard care. Researchers will me…

This study tests whether a single injection of esketamine given during a C-section can lessen severe itching in women with intrahepatic cholestasis of pregnancy, a liver condition that causes intense itch. About 160 women will be randomly assigned to receive either esketamine or …